Publications
16
Citations
107
Est. group size
~4
Recurring co-author estimate
Active years
9
Publishing since 2018
Susantha K. Ganegamage works in medicinal and organic chemistry, with projects spanning the design of small-molecule fluorescent probes, synthesis of heterocyclic compounds, and structure-activity studies related to neurodegenerative disease targets like tau protein aggregation. The work combines chemical synthesis with applications in disease-related research, such as inhibitors for enzymes linked to Parkinson's and Alzheimer's disease, and analytical tools like fluorescent DNA probes. This research sits at the intersection of chemistry and biomedical science, aiming to develop compounds that could inform future therapeutic or diagnostic development.
Publication output was sporadic in earlier years but showed a notable spike in 2023, followed by lower, steady output through 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Synthesis and Photophysical Properties of 1,8-Naphthalimide-Based Dual Fluorescence Probe
Research Square · 2026
- Dual and Panchromatic Emission from <i>N</i>-Aryl-phenanthridinones: Extension of the Seesaw Photophysical Model with a Slight Twist
The Journal of Organic Chemistry · 2023
- Lead modification and structure-activity relationships of halo-substituted amides on inhibition of tau and p-tau aggregation
2023
- Lead modification and structure-activity relationships of halo-substituted amides on inhibition of tau and p-tau aggregation
2023
- Lead modification and structure-activity relationships of halo-substituted amides on inhibition of tau and p-tau aggregation
2023
- Illuminating the G-Quadruplex: A Review on Fluorescent Probes for Detecting Polymorphic G-Quartet DNA Structures
Current Organic Chemistry · 2022
- Reactive CO2 absorption mechanism of a soybean-based (SBB) solvent containing 18 amino acid salts in polyvinylidene fluoride (PVDF) hollow fiber membrane-based gas-liquid membrane contactor
Chemical Engineering Journal · 2020
- Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors
European Journal of Medicinal Chemistry · 2018
- Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors
DORA PSI (Paul Scherrer Institute) · 2018
- ACS Omega×3
- ACS Chemical Neuroscience×2
- Chemical Engineering Journal×1
- Current Organic Chemistry×1
- European Journal of Medicinal Chemistry×1
- Jennifer C. Lee
Medicine · Indiana University
- Jason R. Cannon
Medicine · Purdue University West Lafayette
- Taiwo A. Ademoye
Medicine · Purdue University West Lafayette
- Jessica S. Fortin
Medicine · Purdue University West Lafayette
- Ariane Park
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile